Work

Increased Levels of Inflammatory Proteins, Including TARC / CCL17 , in Skin of AD Patients During JAK Inhibitor Treatment

Year: 2025

Type: article

Source: Clinical & Experimental Allergy

DOI: 10.1111/cea.14637

Authors: Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, C. F. den Hartog Jager, Marlies de Graaf, Marjolein S. de Bruin‐Weller, Femke van Wijk, Edward F. Knol

Institutions: Utrecht University, University Medical Center Utrecht

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,760

Funders: Eli Lilly and Company, Pfizer, Sanofi, LEO Pharma

OpenAlex ID: W4407183527

FWCI: 4.105

Cites: 9

Cited by: 5

Related to: 10